<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01289691</url>
  </required_header>
  <id_info>
    <org_study_id>LHSC2010AAPL</org_study_id>
    <nct_id>NCT01289691</nct_id>
  </id_info>
  <brief_title>Atelectasis After Pulmonary Lobectomy: The Effect Of Air During One-Lung Ventilation (OLV) On Postoperative Atelectasis</brief_title>
  <official_title>Atelectasis After Pulmonary Lobectomy: The Effect Of Air During One-Lung Ventilation (OLV) On Postoperative Atelectasis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>London Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>London Health Sciences Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients scheduled for lung lobe resection using video assisted thoracic surgery will be
      randomly assigned to be ventilated with either only oxygen or a mixture of air and oxygen.

      The primary purpose of this study is to determine if the incidence of postoperative collapse
      (in the non-surgical lung) is decreased when using a mixture of air and oxygen compared to
      using only oxygen (which is our control measurement) during one-lung ventilation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the concerns with all thoracic procedures employing One Lung Ventilation (OLV) is
      intra-operative hypoxia due to the large shunt that develops when only one lung is being
      ventilated. Ventilation with a higher fraction of inspired oxygen (FIO2) is one of the
      commonly chosen strategies for the treatment of hypoxemia during (OLV) for thoracic surgery.
      Using an FIO2 of 1.0 at all times during (OLV), however, may increase the risk of absorption
      atelectasis intra and postoperatively which itself leads to persistent hypoxia and
      potentially pneumonia.

      The aim of this study is therefore to determine the impact of adding air to the inspired
      fraction of oxygen during (OLV) primarily on the incidence of postoperative atelectasis of
      the nonsurgical lung after lung resection using video assisted thoracic surgery and
      secondarily on intraoperative and postoperative oxygenation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">June 2011</completion_date>
  <primary_completion_date type="Anticipated">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of postoperative atelectasis</measure>
    <time_frame>Immediately after the surgery - up to 2 days post operative.</time_frame>
    <description>The primary objective is to determine if the incidence of postoperative atelectasis is decreased in the non-surgical lung, during one-lung ventilation (OLV) with mixture of air and oxygen compared to (OLV) using only oxygen (which is our control measurement) .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of intraoperative and postoperative hypoxia (SpO2 &lt; 90%) .</measure>
    <time_frame>Intra-operative and Post operative day 1 and 2 .</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Pulmonary Atelectasis</condition>
  <arm_group>
    <arm_group_label>Air/Oxygen Mixture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will be ventilated with a mixture of air and oxygen during one lung ventilation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxygen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group will be ventilated with only oxygen during one lung ventilation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>One Lung Ventilation</intervention_name>
    <description>Patients in this group will be ventilated with a mixture of air and oxygen during one lung ventilation.</description>
    <arm_group_label>Air/Oxygen Mixture</arm_group_label>
    <other_name>OLV</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>One Lung Ventilation</intervention_name>
    <description>Patients in this group will be ventilated with only oxygen during one lung ventilation.</description>
    <arm_group_label>Oxygen</arm_group_label>
    <other_name>OLV</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Competent to give consent to enroll in study

          -  Booked for open thoracotomy procedure for lobectomy

          -  American Society of Anesthesiologists comorbidity score 1-4

        Exclusion Criteria:

          -  Unable or unwilling to give consent

          -  Pregnant women

          -  Inability to insert an arterial line

          -  Severe COPD (FEV1 &lt; .7% predicted, or FEV1/FVC &lt; 0.70)

          -  Presence of other significant pulmonary impairment (PaO2 on room air 50 mmHg, PaCO2 &gt;
             50 mmHg or known pulmonary HTN mean PAP &gt; 25 mmHg)

          -  Presence of significant cardiovascular disease (+MIBI that is non-revascularized, CCS
             ≥ 3 angina, NYHA ≥ 3 CHF, EF (by angiography or echocardiogram &lt; 40%)

          -  Chronic renal failure (serum Cr &gt; 200)

          -  Altered liver function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neal Badner, MD, FRCP(C)</last_name>
    <role>Principal Investigator</role>
    <affiliation>London Health Science Centre, University Of Western Ontario</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neal Badner, MD, FRCP(C)</last_name>
    <phone>+1 (519) 685-8500</phone>
    <phone_ext>55115</phone_ext>
    <email>Neal.Badner@lhsc.on.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hesham Youssef, M.B.,B.Ch</last_name>
    <phone>+1 (519) 685-8500</phone>
    <phone_ext>17820</phone_ext>
    <email>heshanm.youssef@lhsc.on.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Victoria Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neal Badner, MD, FRCP(C)</last_name>
      <phone>+1 (519) 685-8500</phone>
      <phone_ext>55115</phone_ext>
      <email>Neal.Badner@lhsc.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Hesham Youssef, M.B.,B.Ch</last_name>
      <phone>+1 (519) 685-8500</phone>
      <phone_ext>17820</phone_ext>
      <email>hesham.youssef@lhsc.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Neal Badner, MD, FRCP(C)</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Rothen HU, Sporre B, Engberg G, Wegenius G, Högman M, Hedenstierna G. Influence of gas composition on recurrence of atelectasis after a reexpansion maneuver during general anesthesia. Anesthesiology. 1995 Apr;82(4):832-42.</citation>
    <PMID>7717553</PMID>
  </reference>
  <reference>
    <citation>Schwarzkopf K, Klein U, Schreiber T, Preussetaler NP, Bloos F, Helfritsch H, Sauer F, Karzai W. Oxygenation during one-lung ventilation: the effects of inhaled nitric oxide and increasing levels of inspired fraction of oxygen. Anesth Analg. 2001 Apr;92(4):842-7.</citation>
    <PMID>11273912</PMID>
  </reference>
  <reference>
    <citation>Rothen HU, Sporre B, Engberg G, Wegenius G, Reber A, Hedenstierna G. Prevention of atelectasis during general anaesthesia. Lancet. 1995 Jun 3;345(8962):1387-91.</citation>
    <PMID>7760608</PMID>
  </reference>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2011</study_first_submitted>
  <study_first_submitted_qc>February 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2011</study_first_posted>
  <last_update_submitted>February 2, 2011</last_update_submitted>
  <last_update_submitted_qc>February 2, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2011</last_update_posted>
  <responsible_party>
    <name_title>Neal Badner</name_title>
    <organization>London Health Sciences Centre</organization>
  </responsible_party>
  <keyword>One Lung Ventilation</keyword>
  <keyword>Atelectasis</keyword>
  <keyword>Oxygenation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Atelectasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

